Infection and infectivity: Utility of rapid antigen tests for the diagnosis of COVID-19

Detection of SARS-CoV-2 proteins is commercially available in the form of lateral-flow rapid antigen test for the point-of-care diagnosis of COVID-19. This platform has been validated for symptomatic and asymptomatic individuals, for diagnosis or screening, and as part of single or sequential diagno...

Full description

Saved in:
Bibliographic Details
Published in:Revista española de quimioterapia 2021-09, Vol.34 Suppl 1 (Suppl 1), p.46-48
Main Authors: Barreiro, P, San-Román, J, Carretero, M M, Candel, F J
Format: Article
Language:English
Subjects:
COVID-19
COVID-19 Nucleic Acid Testing
Humans
Mass Screening
SARS-CoV-2
Sensitivity and Specificity
Update on the management of SARS-CoV-2 infection
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Detection of SARS-CoV-2 proteins is commercially available in the form of lateral-flow rapid antigen test for the point-of-care diagnosis of COVID-19. This platform has been validated for symptomatic and asymptomatic individuals, for diagnosis or screening, and as part of single or sequential diagnostic strategies. Although in general less sensitive than amplification techniques, antigen tests may be particularly valid during the first days of symptoms and to detect individuals with greater viral load, thereby with enhanced chances of viral transmission. The simplicity of antigen tests make them very suitable to discard infection in settings with low pretest probability, and to detect infection in case of higher chances of having COVID-19.
ISSN:0214-3429
1988-9518
DOI:10.37201/req/s01.14.2021